Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Far East Bio Tec Co's total equity for the quarter that ended in Dec. 2025 was NT$587.9 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
The historical data trend for Far East Bio Tec Co's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Far East Bio Tec Co (ROCO:6886) has a Total Equity of NT$587.9 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Far East Bio Tec Co and its competitors.
Is Far East Bio Tec Co's Total Equity too high?
Far East Bio Tec Co's current Total Equity is NT$587.9 Mil. Overall, Far East Bio Tec Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Far East Bio Tec Co's Total Equity compare to KHC and GIS?
Far East Bio Tec Co's Total Equity of NT$587.9 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Far East Bio Tec Co and its competitors. Far East Bio Tec Co's current Total Equity is NT$587.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Far East Bio Tec Co stock overvalued right now?
Based on GuruFocus' analysis, Far East Bio Tec Co (ROCO:6886) is currently considered Fairly Valued. The stock's GF Value™ is NT$48.69, compared to a current price of NT$46.80 — trading 3.9% below its estimated fair value. The current Total Equity is NT$587.9 Mil. Far East Bio Tec Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Far East Bio Tec Co (ROCO:6886), the current Total Equity is NT$587.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Far East Bio Tec Co (ROCO:6886) Overvalued in 2026?
Based on GuruFocus' analysis, Far East Bio Tec Co stock appears to be undervalued.
The current stock price of NT$46.80 is trading 3.9% below its estimated GF Value™ of NT$48.69.
GuruFocus considers Far East Bio Tec Co to be Fairly Valued.
Key valuation signals for ROCO:6886:
Total Equity: NT$587.9 Mil
GF Value™: NT$48.69 vs. price of NT$46.80 (3.9% below fair value)
No single metric tells the full story. See the ROCO:6886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Far East Bio Tec Co Ltd is a manufacturer of Organic Spirulina, Organic Chlorella, Spirulina natural, and Chlorella natural, nutritional supplements. The firm uses fermentation facilities to produce high-quality nattokinase and spore-forming probiotics. Its products comprise products Organic Spirulina, Organic Chlorella, Chlorella Growth Factor, Phycocyanin, Nattokinase, Lactobacillus sporogenes probiotics, Apogen Microalgae Protein, and DHA Algae Oil. Geographically, the company generates the majority of its revenue from Europe followed by Taiwan.
70GF Score
Get the complete analysis for ROCO:6886
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6886 has been successfully added to your 
